Paragon Capital Management Inc Biogen Inc. Transaction History

Paragon Capital Management Inc

  • $136 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Sep 26, 2024
SELL
$275.25 - $318.06 $1.85 Million - $2.14 Million
-6,715 Closed
0 $0
Q1 2023

Sep 26, 2024
BUY
$256.56 - $292.34 $785,843 - $895,437
3,063 Added 83.87%
6,715 $1.87 Billion
Q4 2022

Sep 25, 2024
BUY
$252.44 - $306.72 $921,910 - $1.12 Million
3,652 New
3,652 $1.01 Billion

Others Institutions Holding BIIB

# of Institutions
1,018
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Paragon Capital Management Inc Portfolio

Follow Paragon Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email